What Causes Low Lipase Levels and What Are the Symptoms?

Low lipase levels almost always point to damage, disease, or loss of the pancreatic tissue that produces the enzyme. The pancreas is the body’s main source of lipase, the enzyme responsible for breaking down dietary fat, so when its output drops, fat passes through the gut undigested and a cascade of nutritional problems follows. Chronic pancreatitis is the most common culprit, but the list also includes cystic fibrosis, pancreatic surgery, diabetes, and a handful of rarer conditions. The symptoms tend to be subtle at first and easy to dismiss, which is part of the reason low lipase often goes unrecognized for months or years.

What Lipase Actually Does

Lipase is the enzyme your pancreas secretes into the small intestine to digest dietary fat. Pancreatic lipase is considered the workhorse of fat digestion, responsible for releasing roughly half to two-thirds of the fatty acids from the triglycerides you eat.¹ Without adequate lipase, your body cannot absorb those fatty acids or the fat-soluble vitamins (A, D, E, and K) that travel with them. A related protein called colipase is needed for lipase to work in the environment of the small intestine; without it, even the lipase that is present becomes ineffective.¹

When clinicians talk about “low lipase,” they sometimes mean a low serum lipase level measured in a blood test, and other times they mean low functional lipase output in the gut. Both can signal pancreatic problems, but they are not measuring the same thing. Serum lipase is a snapshot of how much enzyme is leaking into the bloodstream from the pancreas, while functional lipase is about how much enzyme actually reaches the food in the intestine. A blood test showing low serum lipase can be a marker of chronic pancreatic disease even when the patient is not yet showing obvious digestive symptoms.

Chronic Pancreatitis

The single most recognized cause of persistently low lipase is chronic pancreatitis, a condition in which ongoing inflammation slowly destroys the enzyme-producing cells of the pancreas. This destruction is irreversible. Over years, the pancreas progressively loses its ability to secrete adequate digestive enzymes, a state known as exocrine pancreatic insufficiency.² Alcohol use and smoking are the leading drivers of chronic pancreatitis in adults, though genetic factors, autoimmune disease, and recurrent acute pancreatitis also contribute.

In a study comparing chronic pancreatitis patients with healthy controls, mean serum lipase was significantly lower in the patient group (about 16 U/L versus 26 U/L in controls). Nearly one in five patients had lipase levels below a clinically meaningful threshold, and when a cutoff of about 10.5 U/L was used, that test was highly specific for chronic pancreatitis, correctly ruling out healthy people about 96% of the time, though it only caught about a third of actual cases.³ In other words, a very low lipase reading is a strong clue, but a normal reading does not rule the disease out.

Cystic Fibrosis

Cystic fibrosis (CF) damages the pancreas through a completely different route: thick, sticky mucus blocks the ducts that carry enzymes to the intestine, and over time the enzyme-producing tissue scars and shrinks. Newborns with CF often have elevated serum lipase at birth, but in those who carry mutations linked to pancreatic insufficiency, levels decline as damage accumulates during infancy and early childhood. In one study of CF patients carrying two severe mutations, mean serum lipase was about 17 U/L, well below typical values for healthy individuals.⁴ That study also found that low lipase levels tracked closely with the severity of the genetic mutations involved, suggesting the lipase level is largely genetically determined in CF patients.

Shwachman-Diamond syndrome is a much rarer inherited condition that also causes exocrine pancreatic failure, typically presenting in infancy with symptoms of pancreatic insufficiency alongside blood-cell abnormalities and growth problems.⁵ While far less common than CF, it is another genetic pathway to the same outcome: a pancreas that cannot produce enough lipase.

Pancreatic Surgery

Removing part of the pancreas for cancer, severe pancreatitis, or precancerous growths physically eliminates enzyme-producing tissue. The result is predictable: less pancreas, less lipase. Exocrine insufficiency is common after major pancreatic operations, especially the Whipple procedure (pancreatoduodenectomy), where it affects roughly 56 to 98% of patients after surgery. Even before the operation, up to 45% of patients undergoing a Whipple already have insufficient enzyme output, usually because the tumor itself was blocking the pancreatic duct. Distal and central pancreatectomies carry a lower but still substantial risk, with post-surgical insufficiency rates ranging from about 12 to 80%.⁶

This means that nearly everyone who undergoes a Whipple procedure will need lifelong enzyme replacement, and a significant portion of those having less extensive surgeries will too. The degree of insufficiency depends on how much tissue was removed, how well the remaining pancreas is functioning, and whether the surgical reconnection of the pancreatic duct heals properly.

Diabetes and Metabolic Conditions

The connection between low lipase and diabetes is less intuitive, but it is well documented. A systematic review and meta-analysis found that people with both type 1 and type 2 diabetes had significantly lower serum lipase levels compared to healthy individuals. The same analysis found associations between low lipase and excess body fat as well as metabolic syndrome.⁷ The mechanism is not entirely settled, but long-standing diabetes appears to cause gradual pancreatic atrophy, the same organ that loses insulin-producing beta cells also shrinks in its enzyme-producing tissue.

This raises a practical question for people with diabetes who have unexplained digestive complaints: the problem may not be purely a gut issue. If the pancreas is atrophying, enzyme output drops alongside insulin production, and the resulting fat malabsorption can mimic irritable bowel symptoms or be mistaken for dietary intolerance. The metabolic syndrome link suggests this is not limited to people with established diabetes, either; those with pre-diabetic metabolic profiles may also have subtly reduced pancreatic enzyme output.

Celiac Disease and Other Non-Pancreatic Causes

Not every case of low functional lipase traces back to pancreatic disease. In celiac disease, the inflammatory damage to the lining of the small intestine can impair the environment where lipase does its work. About a quarter of celiac patients show reduced intraduodenal lipase activity, meaning the enzyme is not functioning properly even if the pancreas itself is producing a reasonable amount.⁸ For those patients, treating the celiac disease with a strict gluten-free diet may improve fat digestion, but some still benefit from supplemental enzymes in the meantime.

Other conditions that can reduce functional lipase include Zollinger-Ellison syndrome (where excess stomach acid overwhelms the intestinal environment and inactivates enzymes), Crohn’s disease affecting the upper gut, and certain infections or medications that damage the pancreas over time. These are less common but worth knowing about, especially if the standard workup for pancreatic disease comes back clean while symptoms persist.

Digestive Symptoms You Might Notice

The most direct consequence of low lipase is fat malabsorption, and the signature symptom is steatorrhea: pale, bulky, foul-smelling stools that float and are difficult to flush. This happens because undigested fat passes through the intestines and ends up in the stool. In one study of chronic pancreatitis patients, roughly two-thirds had steatorrhea, and their average daily fecal fat was about 9 grams compared to healthy controls’ typical levels.⁹ The coefficient of fat absorption in those patients was about 77%, compared to over 97% in healthy people, meaning they were losing more than a fifth of the fat they ate.⁹

Steatorrhea is not the only digestive complaint. Bloating and abdominal discomfort after fatty meals are common, partly because undigested fat in the intestine triggers different hormonal and mechanical responses than properly digested fat. Research on how fat digestion affects gut sensations has shown that when lipase is blocked experimentally, the gastrointestinal responses to fat change dramatically, including alterations in stomach relaxation and the release of the gut hormone CCK.¹⁰ Diarrhea, gas, and cramping after meals are frequently reported, and many people instinctively start avoiding fatty foods before they ever get a diagnosis, which can mask the problem while creating its own nutritional gaps.

Nutritional Deficiencies and Their Consequences

When fat is not absorbed properly, neither are the vitamins dissolved in it. Vitamins A, D, E, and K all depend on fat for absorption, and deficiencies in these vitamins create a cascade of health effects that may seem completely unrelated to the pancreas. A study of children with chronic pancreatitis found that vitamin D was low in about 22% before surgery and 24% at one year after, vitamin E was low in roughly 17-18%, and vitamin A was low in a smaller percentage. Longer duration of chronic pancreatitis was strongly associated with vitamin D insufficiency.¹¹

These deficiencies matter in practical terms. Low vitamin D weakens bones and increases fracture risk. Low vitamin A affects vision and immune function. Low vitamin E is linked to nerve damage and muscle weakness. Low vitamin K impairs blood clotting. Because these problems develop gradually, they are easy to attribute to aging, poor diet, or other conditions. A person losing bone density, bruising easily, or getting frequent infections might not connect those issues to their pancreas, and neither might their doctor if pancreatic insufficiency is not on the radar.

Muscle Loss and Fatigue

Beyond vitamin deficiencies, poor fat and protein absorption from exocrine pancreatic insufficiency takes a toll on overall body composition. Research in chronic pancreatitis patients has found that those with skeletal muscle loss had lower serum lipase levels and worse nutritional markers than patients without muscle loss.¹² These patients also had weaker grip strength, suggesting the loss is functional, not just measurable on a scan. Pancreatic atrophy and low lipase were among the factors most strongly linked to this muscle wasting.

Unexplained weight loss and persistent fatigue are common complaints that bring patients to the doctor in the first place, and they can easily be chalked up to stress, aging, or depression. When combined with digestive symptoms, though, they form a pattern that should prompt a closer look at pancreatic function. The trouble is that many patients report their digestive complaints as secondary or do not mention them at all, making the connection harder to spot.

How Low Lipase Is Detected

A standard serum lipase blood test can flag an abnormally low reading, but as discussed earlier, a normal blood level does not guarantee normal enzyme function in the gut. When exocrine pancreatic insufficiency is suspected, clinicians often turn to fecal elastase-1 testing, which measures a different pancreatic enzyme in the stool. Elastase-1 is preferred over fecal lipase testing because it has higher sensitivity and less variability between samples. In a head-to-head comparison, the fecal elastase-1 test detected pancreatic insufficiency in about 91% of cases at the same specificity level where the fecal lipase test caught only about 77%, and elastase-1 results varied far less from one stool sample to another.¹³

Other approaches include the 72-hour fecal fat test, which directly measures how much fat is passing through undigested, and breath tests that track how well the body breaks down labeled fat molecules. Imaging with CT or MRI can reveal structural changes in the pancreas, such as calcifications, ductal dilation, or atrophy, that explain why enzyme production has dropped. No single test is definitive on its own; the diagnosis usually comes from combining lab results, imaging, and the clinical picture.

Enzyme Replacement Therapy

The primary treatment for low lipase due to exocrine pancreatic insufficiency is pancreatic enzyme replacement therapy, or PERT. These are capsules containing a mix of lipase, protease, and amylase derived from pig pancreases, taken with every meal and snack. PERT is considered safe and effective at treating the condition.¹⁴ A meta-analysis found that PERT significantly improved fat absorption compared to both baseline and placebo, with parallel improvements in protein absorption, stool fat, and stool weight.¹⁵

Dosing matters more than many patients realize. A systematic review of real-world dosing found that even lower-than-recommended enzyme doses could ease diarrhea in most studies, but only guideline-compliant doses consistently improved or maintained nutritional status.¹⁶ In practice, this means that a patient who feels their stool has improved on a low dose may still be malnourished because fat and vitamin absorption remain inadequate. The capsules need to be taken at the right time (with food, not an hour before or after), in sufficient quantity, and consistently with every fat-containing meal.

Beyond PERT, management usually includes supplementation of fat-soluble vitamins, dietary counseling to balance fat intake (not eliminate it, since fat carries essential nutrients), and treatment of the underlying condition when possible. For celiac disease, a gluten-free diet may restore enough intestinal function that enzyme supplements become unnecessary. For chronic pancreatitis, controlling alcohol use and managing pain can slow further pancreatic damage, though the lost tissue does not regenerate.

When Low Lipase Shows Up Without Obvious Cause

Occasionally, a routine blood panel turns up a low serum lipase level in someone who is not experiencing digestive symptoms and has no known pancreatic disease. This can be confusing, and the honest answer is that a low lipase value on its own is neither a diagnosis nor something to ignore. It does not establish a pancreatic disorder, but it does not rule one out either. The context matters enormously: someone with a borderline low lipase and no symptoms is in a different situation from someone with the same number plus bloating, oily stools, and unexplained weight loss.

The metabolic syndrome data mentioned earlier suggest that subclinical pancreatic changes can lower serum lipase before any digestive symptoms appear. For people with type 2 diabetes or significant obesity, a low serum lipase level could be an early signal of pancreatic atrophy worth monitoring over time, especially if digestive complaints develop later.⁷ In children, a declining serum lipase trend can be among the first clues to cystic fibrosis or Shwachman-Diamond syndrome, sometimes appearing before more classic symptoms like recurrent lung infections or failure to thrive.⁴

If your lipase comes back low and you are not sure what to make of it, the most useful next step is usually a conversation with the clinician who ordered the test, along with a careful inventory of any digestive symptoms you may have been dismissing. Mild steatorrhea, vague post-meal discomfort, and gradual weight changes are easy to normalize, especially if they developed slowly. A fecal elastase test and a look at fat-soluble vitamin levels can clarify whether the low lipase is an incidental lab finding or the tip of something more significant.

1
Asian-Australasian Journal of Animal Sciences. Principles of Physiology of Lipid Digestion
2
PubMed Central. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management
3
PubMed Central. Can We Detect Chronic Pancreatitis With Low Serum Pancreatic Enzyme Levels?
4
PubMed. Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests
5
PubMed. Shwachman-Diamond syndrome: clinical phenotypes
6
PubMed. Pancreatic exocrine insufficiency following pancreatic resection
7
PubMed. Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: A systematic review and meta-analysis
8
PubMed. Intraduodenal lipase activity in celiac disease assessed by means of 13C mixed-triglyceride breath test
9
Journal of Gastroenterology. Steatorrhea in Japanese patients with chronic pancreatitis
10
Gastroenterology. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans
11
PubMed Central. Fat soluble vitamin deficiency is common in children with chronic pancreatitis undergoing TPIAT
12
PubMed. Skeletal muscle mass and function are affected by pancreatic atrophy, pancreatic exocrine insufficiency and poor nutritional status in patients with chronic pancreatitis
13
PubMed. Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis
14
PubMed Central. Pancreatic Enzyme Replacement Therapy: A Concise Review
15
PubMed Central. Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis
16
PubMed Central. Pancreatic Enzyme Replacement Therapy in Pancreatic Exocrine Insufficiency-Real-World’s Dosing and Effectiveness: A Systematic Review